#ASPChat Transcript
Healthcare social media transcript of the #ASPChat hashtag.
– ().
See #ASPChat Influencers/Analytics.
| Profile | Tweet |
|---|---|
 | David Ha @DHpharmd RT @ASP_Chat: Q1. What is 💥 new in 2018 with the use of rapid diagnostics for antimicrobial stewardship activities? #ASPchat https://t.co/yhvk84YcVs |
 | Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @ASP_Chat A1. I am not sure what we could say is new this year specifically, but following @TheIDApprentice @TimbrookTT @real_idpharmd @manfordou @idpharmd and a few others sure makes me feel like I am in the loop on what's new! #ASPchat |
 | CDC Emerging Infections @CDC_NCEZID CDC is excited to be a part of tonight’s #ASPChat and share our educational resources for antibiotic stewardship. https://t.co/m65PM0ZXWT #BeAntibioticsAware |
 | Jordan Wong @real_idpharmd RT @CDC_NCEZID: CDC is excited to be a part of tonight’s #ASPChat and share our educational resources for antibiotic stewardship. https://t.co/m65PM0ZXWT #BeAntibioticsAware |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @CDC_NCEZID: CDC is excited to be a part of tonight’s #ASPChat and share our educational resources for antibiotic stewardship. https://t.co/m65PM0ZXWT #BeAntibioticsAware |
| Jordan Wong @real_idpharmd #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship #ASPchat |
| Jordan Wong @real_idpharmd @DHpharmd @TheIDApprentice @IDstewardship @ASP_Chat @TimbrookTT @manfordou @idpharmd @AXDXNews Don't feel bad David, very hard to keep up with this technology since there are so many great RDT out there. Grateful for companies making investments as it's changing practice #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @real_idpharmd @DHpharmd @TheIDApprentice @ASP_Chat @TimbrookTT @manfordou @idpharmd @AXDXNews Anyone have a good way for keeping up with what's new with all the different #rapiddx companies? Just visit websites or any other tips? #ASPchat |
 | Nick Bennett @nbennett04 @ASP_Chat There is finally widespread acceptance (or maybe I’m biased), that RDTs Work best with stewardship input. It’s a culmination of many papers sugg so, including the 👍 meta analysis by @TimbrookTT not long ago #ASPChat |
 | #ASPchat @ASP_Chat Q2. In your opinion, what is the most 🙌🏼 game-changing rapid diagnostic test out there? Why? #ASPchat [feel free to take a quantity or quality perspective] https://t.co/3sPZ6G1FUV |
| Jordan Wong @real_idpharmd @TheIDApprentice @IDstewardship @ASP_Chat @TimbrookTT @manfordou @idpharmd Eric, you make a great point about cost effectiveness. It goes a long way to support the intervention 👌🏽and the antimicrobial stewardship program #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_Chat: Q2. In your opinion, what is the most 🙌🏼 game-changing rapid diagnostic test out there? Why? #ASPchat [feel free to take a quantity or quality perspective] https://t.co/3sPZ6G1FUV |
| Nick Bennett @nbennett04 RT @IDstewardship: @ASP_Chat A1. I am not sure what we could say is new this year specifically, but following @TheIDApprentice @TimbrookTT @real_idpharmd @manfordou @idpharmd and a few others sure makes me feel like I am in the loop on what's new! #ASPchat |
| David Ha @DHpharmd @nbennett04 @ASP_Chat @TimbrookTT @TheIDApprentice @real_idpharmd #ASPchat |
| Jordan Wong @real_idpharmd It's the one you use to optimize patient outcomes. Hard to pick just one since each institution can individualize for their respective problem pathogens #loadedquestion #ASPchat |
 | Brad Langford @BRxAD @ASP_Chat Our community hospital in Toronto, Canada has begun to integrate MALDI-TOF into laboratory testing, but seems like overall less activity in Canada compared to US. Hard to keep up with all the new RDT technology! #ASPchat |
 | Brad Crane @ASP_PharmD @ASP_Chat .@AXDXNews is probably one of the new hot topics, doing phenotypic results not just genotypic. Still early but big difference/step from other genotypic options. #ASPchat |
| CDC Emerging Infections @CDC_NCEZID Download CDC’s Core Elements of Outpatient Antibiotic Stewardship as a how-to guide: https://t.co/bAdbnZqAoF #ASPChat #BeAntibioticsAware https://t.co/jfRdkhommb |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @ASP_Chat A2. Rapid differentiation of MSSA versus MRSA bloodstream infection is probably my favorite, but being able to call something a carbapenemase-producer so early on and thus potentially catch ur are missing it with ur empiric therapy, well that's pretty darn awesome too. #ASPchat |
| David Ha @DHpharmd Yes couldn't agree more. With more systems on the market need to consider cost effectiveness from the standpoint of not just cost-per-test but also the diversity of tests that can be performed on a single platform (e.g. 1 platform 3 tests vs. 3 platforms 1 test). #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @nbennett04: @ASP_Chat There is finally widespread acceptance (or maybe I’m biased), that RDTs Work best with stewardship input. It’s a culmination of many papers sugg so, including the 👍 meta analysis by @TimbrookTT not long ago #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @BRxAD: @ASP_Chat Our community hospital in Toronto, Canada has begun to integrate MALDI-TOF into laboratory testing, but seems like overall less activity in Canada compared to US. Hard to keep up with all the new RDT technology! #ASPchat |
| David Ha @DHpharmd With the latter, need to consider background costs of maintaining QC on 3 different platforms and also laboratory space... Bottom line: Involve your #Laboratory #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @CDC_NCEZID: Download CDC’s Core Elements of Outpatient Antibiotic Stewardship as a how-to guide: Download CDC’s Core Elements of Outpatient Antibiotic Stewardship as a how-to guide: https://t.co/bAdbnZqAoF #ASPChat #BeAntibioticsAware https://t.co/jfRdkhommb |
 | Erica K. Little @CefidErica RT @ASP_Chat: 👋🏼 Welcome to the #ASPchat on rapid diagnostics and antimicrobial stewardship! We’re glad to have you along!!! **Remember to use #ASPchat in your tweets so everyone can follow the discussion** ...starting in just ⏱ a few minutes... https://t.co/6o4VBbq4pk |
| Erica K. Little @CefidErica RT @nbennett04: @ASP_Chat There is finally widespread acceptance (or maybe I’m biased), that RDTs Work best with stewardship input. It’s a culmination of many papers sugg so, including the 👍 meta analysis by @TimbrookTT not long ago #ASPChat |
| Brad Langford @BRxAD @IDstewardship @real_idpharmd @DHpharmd @TheIDApprentice @ASP_Chat @TimbrookTT @manfordou @idpharmd @AXDXNews From a publications perspective - @CIDRAP_ASP seems to be on the ball with all of the new RDT related literature: https://t.co/A5kbnOu1yc #ASPChat |
| David Ha @DHpharmd RDT + ASP so important. Oldie but goodie article from Sara Cosgrove and Pranita Tamma on lack of outcomes when RDT implemented without ASP support. #ASPchat https://t.co/qIDZS9Lp8T |
| Brad Crane @ASP_PharmD @IDstewardship @ASP_Chat .@Luminex @BioFireDX and others don't limit MSSA vs MRSA but also identify enterococcus (incl VRE), streps and various GNR (including ESBL and less frequent CREs) #ASPchat |
 | Dr.houssein jaffal 🇩🇪🇩🇪🇩🇪 @jaffal13 RT @IDstewardship: @ASP_Chat A2. Rapid differentiation of MSSA versus MRSA bloodstream infection is probably my favorite, but being able to call something a carbapenemase-producer so early on and thus potentially catch ur are missing it with ur empiric therapy, well that's pretty darn awesome too. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @BRxAD: @IDstewardship @real_idpharmd @DHpharmd @TheIDApprentice @ASP_Chat @TimbrookTT @manfordou @idpharmd @AXDXNews From a publications perspective - @CIDRAP_ASP seems to be on the ball with all of the new RDT related literature: https://t.co/A5kbnOu1yc #ASPChat |
| Erica K. Little @CefidErica RT @ASP_PharmD: @ASP_Chat .@AXDXNews is probably one of the new hot topics, doing phenotypic results not just genotypic. Still early but big difference/step from other genotypic options. #ASPchat |
 | Rodney E. Rohde, PhD "Doc R" @RodneyRohde @ASP_Chat A1 - Hoping @MaureenSpence24 will chime in about the exciting new #AcceleratePhenotype system for ID /AST in ~7h via #FISH probes for ID & Morphokinetic changes in presence of Abx for AST! #ASPChat |
| #ASPchat @ASP_Chat Q3. What do you see as the most ☝🏼 critical element towards making rapid diagnostic tests successful? #ASPchat |
| Nick Bennett @nbennett04 @DHpharmd @ASP_Chat @TimbrookTT @TheIDApprentice @real_idpharmd #ASPChat |
| Jordan Wong @real_idpharmd @ASP_PharmD The "real estate" on AST is a big win! Difference of MIC of </=4, vs </=16 for pip-tazo could swing your decision when treating Pseudomonas #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @RodneyRohde: @ASP_Chat A1 - Hoping @MaureenSpence24 will chime in about the exciting new #AcceleratePhenotype system for ID /AST in ~7h via #FISH probes for ID & Morphokinetic changes in presence of Abx for AST! #ASPChat |
| Brad Crane @ASP_PharmD Agree with this. Major lab barrier. Seems like the "best" options are on different platforms but difficult for lab to host all - QC, room, bundling options - plus rapidly changing technology hard to commit to contracts. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @RodneyRohde @ASP_Chat @MaureenSpence24 👆 That sounds really really cool! #ASPchat |
| Jordan Wong @real_idpharmd @DHpharmd To piggy back, another one for no ASP with RDT showing no difference in outcomes #ASPchat https://t.co/NEqEPmIqBk |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @real_idpharmd: It's the one you use to optimize patient outcomes. Hard to pick just one since each institution can individualize for their respective problem pathogens #loadedquestion #ASPchat |
 | Monica Mahoney @mmPharmD A3. As seen over and over in studies, if you build it, they won't come. You need dedicated ASP personnel to make it successful. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_Chat: Q3. What do you see as the most ☝🏼 critical element towards making rapid diagnostic tests successful? #ASPchat |
| David Ha @DHpharmd @ASP_Chat Whether it's a #pharmacist or other clinician, stewardship team engagement really important. Even with good micro reporting, to the everyday clinician, tests are complicated, have caveats and unclear how much trust to put in them, need stewardship to support #ASPchat |
| David Ha @DHpharmd RT @ASP_PharmD: Agree with this. Major lab barrier. Seems like the "best" options are on different platforms but difficult for lab to host all - QC, room, bundling options - plus rapidly changing technology hard to commit to contracts. #ASPchat |
| Monica Mahoney @mmPharmD @dest12 Do you have collaborative practice agreements to automatically change orders? #ASPchat |
| Brad Langford @BRxAD @ASP_Chat ASP involvement in RDT and integrating with prospective audit and feedback is clearly a critical step. ASP may also identify more #stewardly alternative options. E.g., better to D/C antibiotics when not indicated than to modify therapy #ASPchat |
 | Jamie Kisgen @KisgenUF Stewardship review and feedback are key! Providers need to know role, limitations, and turnaround of tests. They also need to know how to order to (e.g. Meningitis Panel with LP). Can’t use it if you don’t order it! #ASPChat |
| David Ha @DHpharmd RT @real_idpharmd: @DHpharmd To piggy back, another one for no ASP with RDT showing no difference in outcomes #ASPchat https://t.co/NEqEPmIqBk |
| David Ha @DHpharmd RT @BRxAD: @IDstewardship @real_idpharmd @DHpharmd @TheIDApprentice @ASP_Chat @TimbrookTT @manfordou @idpharmd @AXDXNews From a publications perspective - @CIDRAP_ASP seems to be on the ball with all of the new RDT related literature: https://t.co/A5kbnOu1yc #ASPChat |
 | Chris Bland @blandman19 RT @real_idpharmd: It's the one you use to optimize patient outcomes. Hard to pick just one since each institution can individualize for their respective problem pathogens #loadedquestion #ASPchat |
| David Ha @DHpharmd @BRxAD @IDstewardship @real_idpharmd @TheIDApprentice @ASP_Chat @TimbrookTT @manfordou @idpharmd @AXDXNews @CIDRAP_ASP Nice! Bookmarking this one 👍 #ASPchat |
| Nick Bennett @nbennett04 @ASP_Chat Love MALDI on blood cx but waiting for day where it can be done on whole blood samples. Too slow now vs pcr. Wishful thinking?🤷♂️ Have to say that us (asp) comm all blood cx results has been most impactful (9.2 hrs decr in time to optimal Rx) #ASPChat |
| CDC Emerging Infections @CDC_NCEZID Healthcare professionals: Section 2 of CDC’s online training course on antibiotic stewardship is now available. Receive free CE. Create an account or log in to register: https://t.co/j3Lp0wgGDm #ASPChat #BeAntibioticsAware https://t.co/cYkzJ6EfQx |
| Nick Bennett @nbennett04 RT @DHpharmd: @ASP_Chat Whether it's a #pharmacist or other clinician, stewardship team engagement really important. Even with good micro reporting, to the everyday clinician, tests are complicated, have caveats and unclear how much trust to put in them, need stewardship to support #ASPchat |
| Monica Mahoney @mmPharmD @nbennett04 @ASP_Chat Isn't that Accelerate pheno? T2 or something? #ASPchat |
| Rodney E. Rohde, PhD "Doc R" @RodneyRohde @IDstewardship @dest12 @romneyinla Another issue is how important a #MedicalLaboratory professional and/or a #DCLS like @BnrdG is in Knowing WHICH rapid test to order based on #patient case AND the subsequent interpretation of the complex results esp #Molecular platforms! #ASPChat |
| David Ha @DHpharmd So important 👇 #ASPchat |
| Brad Crane @ASP_PharmD @KisgenUF Pharmacists can help with provider lack of knowledge. Lots easier to educate clinical pharmacy staff (or selected providers) vs all providers. In addition to interpreting results correctly, we incorporate stewardship principles at same time. #ASPchat |
| Jamie Kisgen @KisgenUF RT @BRxAD: @IDstewardship @real_idpharmd @DHpharmd @TheIDApprentice @ASP_Chat @TimbrookTT @manfordou @idpharmd @AXDXNews From a publications perspective - @CIDRAP_ASP seems to be on the ball with all of the new RDT related literature: https://t.co/A5kbnOu1yc #ASPChat |
| Chris Bland @blandman19 @ASP_Chat I would add be sure and educate your nurses too. If they are receiving calls from lab saying “Staph aureus MecA gene not detected vs GPC in clusters” and haven’t been educated then lots of misinformation could be given ultimately to providers. #aspchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @ASP_Chat It of course varies by site, but I feel like provider engagement is maybe the most important thing. Once the MDs start asking for something, people start paying more attention, it drives change. #ASPchat |
| Rodney E. Rohde, PhD "Doc R" @RodneyRohde RT @DHpharmd: @ASP_Chat Whether it's a #pharmacist or other clinician, stewardship team engagement really important. Even with good micro reporting, to the everyday clinician, tests are complicated, have caveats and unclear how much trust to put in them, need stewardship to support #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @blandman19: @ASP_Chat I would add be sure and educate your nurses too. If they are receiving calls from lab saying “Staph aureus MecA gene not detected vs GPC in clusters” and haven’t been educated then lots of misinformation could be given ultimately to providers. #aspchat |
| Jordan Wong @real_idpharmd @ASP_Chat Work with micro lab 🦠🔬 to provide the most succcess with RDTs. Coordinate efforts to allow the ASP to be effective. No point in batching RDTs so by the time you get results the ASP will report to cross cover you may not be able to act 😞 #ASPchat |
| Chris Bland @blandman19 RT @ASP_PharmD: @KisgenUF Pharmacists can help with provider lack of knowledge. Lots easier to educate clinical pharmacy staff (or selected providers) vs all providers. In addition to interpreting results correctly, we incorporate stewardship principles at same time. #ASPchat |
| #ASPchat @ASP_Chat 🚨 Half-Time Warning 🚨 Brought to you by.... #ASPchat folks, get 15% off membership now through 8/20/2018. 🗣 Tell your students, residents, and fellows, they will be 😃 very happy with you! #LearnABX #SaveABX https://t.co/Dz6TxpsNcE https://t.co/vTJy1dkuDG |
| #ASPchat @ASP_Chat Q4. What approaches can stewardship programs 👀 look to in order to 💰✅ cost-justify / prove the value of rapid molecular diagnostic test locally? #ASPchat Gif of the admin you need to convince... https://t.co/txXw5AcCrY |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_Chat: 🚨 Half-Time Warning 🚨 Brought to you by.... #ASPchat folks, get 15% off membership now through 8/20/2018. 🗣 Tell your students, residents, and fellows, they will be 😃 very happy with you! #LearnABX #SaveABX https://t.co/Dz6TxpsNcE https://t.co/vTJy1dkuDG |
| Brad Crane @ASP_PharmD Believe @bruker has their MALDI available with an accessory that can test whole blood. Currently RUO but is hoping to have FDA approval in 2019. Will potentially replace need for other molecular platforms except for resistance determinants #ASPchat |
| Jordan Wong @real_idpharmd @ASP_Chat #teamwork #ASPchat https://t.co/F26he8UyaW |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_Chat: Q4. What approaches can stewardship programs 👀 look to in order to 💰✅ cost-justify / prove the value of rapid molecular diagnostic test locally? #ASPchat Gif of the admin you need to convince... https://t.co/txXw5AcCrY |
| Rodney E. Rohde, PhD "Doc R" @RodneyRohde A3 - The intersection btw #DiagnosticManagementTeams will be CRITICAL for any successful implementation! #ASPChat Of Course, Including the #MedicalLaboratory #DCLS @ASCLS @RutgersU @utmbhealth @BnrdG |
| David Ha @DHpharmd RT @real_idpharmd: @ASP_Chat Work with micro lab 🦠🔬 to provide the most succcess with RDTs. Coordinate efforts to allow the ASP to be effective. No point in batching RDTs so by the time you get results the ASP will report to cross cover you may not be able to act 😞 #ASPchat |
| Rodney E. Rohde, PhD "Doc R" @RodneyRohde RT @real_idpharmd: It's the one you use to optimize patient outcomes. Hard to pick just one since each institution can individualize for their respective problem pathogens #loadedquestion #ASPchat |
| Brad Crane @ASP_PharmD Our protocol is that micro calls nurses on gram stain (critical result) but micro calls pharmacy with rapid test result. Pharmacist then determines need to notify physician or not (usually as FYI or if changes recommended) #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @ASP_Chat If i was trying to bring a new test to a hospital or hospitals, I feel like pre-meeting coordination would be huge, then bring a thoughtful plan on how a system can be implemented and show lab, ID, pharmacy, other support exists for it... and need some local data too. #ASPchat |
| David Ha @DHpharmd @ASP_PharmD @bruker Had also heard rumors about identifying resistance proteins (beta lactamases, modifying enzymes) that could predict susceptibility... 🤤 #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_PharmD: @IDstewardship @ASP_Chat .@Luminex @BioFireDX and others don't limit MSSA vs MRSA but also identify enterococcus (incl VRE), streps and various GNR (including ESBL and less frequent CREs) #ASPchat |
 | Accelerate @AXDXNews @DHpharmd @TheIDApprentice @IDstewardship @ASP_Chat @TimbrookTT @real_idpharmd @manfordou @idpharmd We're here when you need us @DHpharmd! And while the fully automated FISH is cool, watching bugs grow, and getting you MICs much earlier is our thing. #antibiotics #ASPchat |
| Monica Mahoney @mmPharmD @ASP_Chat Identify staph earlier and get that rifampin off the patients sooner so they dont turn into oompa loompas? #ASPchat https://t.co/7tzR5Op0P2 |
| Jamie Kisgen @KisgenUF Need to support your micro lab with the ROI up front. Most hospital dept budgets are in silos and they will need ASP help to justify new capital & operational expense. Great opportunity for a student or resident research/MUE after implentation. #ASPchat |
| Rodney E. Rohde, PhD "Doc R" @RodneyRohde #ASPChat I’m a BIG proponent of #rapiddx #RapidDiagnostics BUT....imo, it will be important to have folks around that understand the other gold std tests When needed! |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_PharmD: Agree with this. Major lab barrier. Seems like the "best" options are on different platforms but difficult for lab to host all - QC, room, bundling options - plus rapidly changing technology hard to commit to contracts. #ASPchat |
| Brad Crane @ASP_PharmD Batching can be appropriate for some molecular tests (MRSA PCR testing, maybe CDiff) but ideally not potentially critical labs like blood cultures. Micro processes, especially when not open 24/7 usually drive this need, plus technology available. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @real_idpharmd: @DHpharmd To piggy back, another one for no ASP with RDT showing no difference in outcomes #ASPchat https://t.co/NEqEPmIqBk |
| Brad Langford @BRxAD @ASP_Chat It is a challenge to use antibiotic cost savings alone to justify RDT. Need to take a quality perspective and also consider downstream outcomes that can prove more costly (e.g., impact of less effective therapy, LOS, CDI). #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @DHpharmd: @ASP_Chat Whether it's a #pharmacist or other clinician, stewardship team engagement really important. Even with good micro reporting, to the everyday clinician, tests are complicated, have caveats and unclear how much trust to put in them, need stewardship to support #ASPchat |
| Brad Crane @ASP_PharmD oh, and bring donuts to the micro lab #ASPchat |
| Monica Mahoney @mmPharmD @ASP_Chat A4. For real now. Demonstrate shorter LOS. Decreased abx use. Decreased DOT/DDD. Cost savings? And the holy grail - decreased mortality. Basically, outline your metrics before, gather baseline data, then show ROI. #ASPchat |
| Monica Mahoney @mmPharmD So true, so important, so sad 😞 #ASPchat |
| Brad Crane @ASP_PharmD A4. We did pilot study - used it and compared outcomes (antibiotic utilization but especially ICU & hospital LOS & costs) - when I showed NET savings of $600k/year (incorporating cost of RDT), much easier to keep it going. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @DHpharmd @ASP_Chat I can imagine... "hello, this is stewardship support. David speaking, how can we help you today?" #ASPchat ...Put those IT + customer service + ID + microbiology + pharmacy operations + communication skills to the test! |
| Jamie Kisgen @KisgenUF @ASP_PharmD Great advice, right @blandman19 👍 🍩 #Teamwork #ASPChat https://t.co/WSJ9CRBZuY |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @KisgenUF: Stewardship review and feedback are key! Providers need to know role, limitations, and turnaround of tests. They also need to know how to order to (e.g. Meningitis Panel with LP). Can’t use it if you don’t order it! #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_PharmD: @KisgenUF Pharmacists can help with provider lack of knowledge. Lots easier to educate clinical pharmacy staff (or selected providers) vs all providers. In addition to interpreting results correctly, we incorporate stewardship principles at same time. #ASPchat |
| Monica Mahoney @mmPharmD @ASP_PharmD Even better if you can contract with a diagnostics company to "donate" equipment for a "study". #ASPchat (full disclosure: we haven't been able to do this) 😢 |
| Jordan Wong @real_idpharmd @KisgenUF agree with the MUE/resident research. Presented on Pharmacy Rules Everything Around MUEs #PREAM at @GSHPofficial meeting, one point made was when presenting data to C-suite, you should align your outcomes with senior leadership goal to better speak to admin #ASPchat |
| CDC Emerging Infections @CDC_NCEZID #BeAntibioticsAware materials for patients and healthcare providers are available in a variety of languages. #ASPChat https://t.co/sP1DnjF4dY |
| Brad Crane @ASP_PharmD I think lab appreciates it when pharmacy to the C-Suite asking for funds for the lab. #ASPchat |
| David Ha @DHpharmd Would say that 100% cost justification is often unrealistic, improvement in patient care (more optimal infxn treatment, maybe LOS) is the winner. Bring multiple disciplines &influential people (e.g. physician leaders) into the mix and you have a strong argument #ASPchat |
| #ASPchat @ASP_Chat Q5. Do you have a favorite 📄 article/ 📱resource on rapid diagnostics that has been published in the last year or that you most often refer to? #ASPchat Some have been noted already, don’t hesitate to share your favs again in case others late to the party missed it! https://t.co/tJNcpekdul |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @nbennett04: @ASP_Chat Love MALDI on blood cx but waiting for day where it can be done on whole blood samples. Too slow now vs pcr. Wishful thinking?🤷♂️ Have to say that us (asp) comm all blood cx results has been most impactful (9.2 hrs decr in time to optimal Rx) #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship Easy, relevant, open-access, and I 💚 it! #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @RodneyRohde @dest12 @romneyinla @BnrdG I wonder if there are data out there on how well lab techs understand rapid diagnostics and how to ensure the tests are optimized? Is that so basic there would be no need to try to assess it? #ASPchat |
| Rodney E. Rohde, PhD "Doc R" @RodneyRohde RT @IDstewardship: @RodneyRohde @ASP_Chat @MaureenSpence24 👆 That sounds really really cool! #ASPchat |
| Accelerate @AXDXNews @DHpharmd @TheIDApprentice @IDstewardship @ASP_Chat @TimbrookTT @real_idpharmd @manfordou @idpharmd Some refer to it as morphokinetic cellular analysis. We look at the change in morphology of live cells over time under challenge of antibiotics. Dynamic dillution is our way of making it easy for lab techs - it's how we standardize the inocula. No .5 McFarland. #ASPchat |
| Jamie Kisgen @KisgenUF 👇So important. Great work! #PREAM #ASPChat |
| David Ha @DHpharmd @SMcGrathICP @mmPharmD @ASP_Chat Check out https://t.co/rLOmQMAuNq for a nice review of literature on RDTs for BSI #ASPchat |
| Monica Mahoney @mmPharmD @KisgenUF #LivingThePREAM #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @real_idpharmd: @ASP_Chat Work with micro lab 🦠🔬 to provide the most succcess with RDTs. Coordinate efforts to allow the ASP to be effective. No point in batching RDTs so by the time you get results the ASP will report to cross cover you may not be able to act 😞 #ASPchat |
| Brad Crane @ASP_PharmD I try to share our RDT data outcomes with the micro department specifically, so they see the downsteam impact of their efforts, especially since most RDT is additional work to the current process, not a replacement #ASPchat |
| Monica Mahoney @mmPharmD @ASP_Chat Wait until January in #JALM 🤣 @BWDionne @TimbrookTT @MayaBeganovic1 #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship Can we go one #ASPchat without bringing up 🍩 doughnuts??? 🤣 |
| Jordan Wong @real_idpharmd @ASP_Chat When teaching the ID pharmacy residents I start with: @TheBack140 who started this game changing practice https://t.co/zSDm6zqEJS Another underrated article in my opinion as it has cost analysis https://t.co/nTKMf7TaLb And a general review https://t.co/0IgRwepCb0 #ASPchat |
| Brad Langford @BRxAD RT @DHpharmd: @SMcGrathICP @mmPharmD @ASP_Chat Check out https://t.co/rLOmQMAuNq for a nice review of literature on RDTs for BSI #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_PharmD: Believe @bruker has their MALDI available with an accessory that can test whole blood. Currently RUO but is hoping to have FDA approval in 2019. Will potentially replace need for other molecular platforms except for resistance determinants #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @RodneyRohde: A3 - The intersection btw #DiagnosticManagementTeams will be CRITICAL for any successful implementation! #ASPChat Of Course, Including the #MedicalLaboratory #DCLS @ASCLS @RutgersU @utmbhealth @BnrdG |
| Jamie Kisgen @KisgenUF RT @ASP_PharmD: I think lab appreciates it when pharmacy to the C-Suite asking for funds for the lab. #ASPchat |
| Monica Mahoney @mmPharmD @SMcGrathICP @DHpharmd So important. This has been a big reason our RDT implementation has not been ... rapid. Short staffed micro = short staffed hospital! #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @ASP_PharmD Was it hard to sell micro on making all of those phone calls? #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @AXDXNews: @DHpharmd @TheIDApprentice @IDstewardship @ASP_Chat @TimbrookTT @real_idpharmd @manfordou @idpharmd We're here when you need us @DHpharmd! And while the fully automated FISH is cool, watching bugs grow, and getting you MICs much earlier is our thing. #antibiotics #ASPchat |
| Jamie Kisgen @KisgenUF RT @real_idpharmd: @ASP_Chat When teaching the ID pharmacy residents I start with: @TheBack140 who started this game changing practice https://t.co/zSDm6zqEJS Another underrated article in my opinion as it has cost analysis https://t.co/nTKMf7TaLb And a general review https://t.co/0IgRwepCb0 #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @mmPharmD: @ASP_Chat Identify staph earlier and get that rifampin off the patients sooner so they dont turn into oompa loompas? #ASPchat https://t.co/7tzR5Op0P2 |
 | khin @khinkchaw RT @IDstewardship: Easy, relevant, open-access, and I 💚 it! #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @KisgenUF: Need to support your micro lab with the ROI up front. Most hospital dept budgets are in silos and they will need ASP help to justify new capital & operational expense. Great opportunity for a student or resident research/MUE after implentation. #ASPchat |
 | Doctor Fungus @DrFungus_MSGERC RT @CDC_NCEZID: CDC is excited to be a part of tonight’s #ASPChat and share our educational resources for antibiotic stewardship. https://t.co/m65PM0ZXWT #BeAntibioticsAware |
| Brad Crane @ASP_PharmD @IDstewardship Initially, yes. But when micro realizes I/we speak their language and they won't have to answer a ton of questions back from nurses/physicians, they realize pharmacists are likely the most efficient people to call for this specific test. #ASPchat |
| #ASPchat @ASP_Chat Q6. What is on your 📝 wish-list for rapid diagnostic tests of the future? #ASPchat 🤔 https://t.co/2hwTeBmL4N |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @BRxAD: @ASP_Chat It is a challenge to use antibiotic cost savings alone to justify RDT. Need to take a quality perspective and also consider downstream outcomes that can prove more costly (e.g., impact of less effective therapy, LOS, CDI). #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @mmPharmD: @ASP_Chat A4. For real now. Demonstrate shorter LOS. Decreased abx use. Decreased DOT/DDD. Cost savings? And the holy grail - decreased mortality. Basically, outline your metrics before, gather baseline data, then show ROI. #ASPchat |
| CDC Emerging Infections @CDC_NCEZID #BeAntibioticsAware static clings and stickers now available to order via CDC-INFO On Demand! Visit https://t.co/Q6HxPmDlm8 and select “antibiotic use” from the drop-down menu. #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @manfordou @ASP_PharmD Wait... you can't be bringing food into the micro lab!!! #ASPchat |
| Chris Bland @blandman19 RT @KisgenUF: @ASP_PharmD Great advice, right @blandman19 👍 🍩 #Teamwork #ASPChat https://t.co/WSJ9CRBZuY |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_Chat: Q5. Do you have a favorite 📄 article/ 📱resource on rapid diagnostics that has been published in the last year or that you most often refer to? #ASPchat Some have been noted already, don’t hesitate to share your favs again in case others late to the party missed it! https://t.co/tJNcpekdul |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_Chat: Q6. What is on your 📝 wish-list for rapid diagnostic tests of the future? #ASPchat 🤔 https://t.co/2hwTeBmL4N |
| Monica Mahoney @mmPharmD @ASP_Chat A6. To have some? 😭 #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @ASP_Chat Essentially, I want one of these... can we make that happen? #ASPchat https://t.co/wrX62cjFY1 |
| Jordan Wong @real_idpharmd @ASP_Chat @TheBack140 Other ones by @TheIDApprentice https://t.co/hNq02zC3Pp @TimbrookTT https://t.co/u4iwZfoDvY MALDI and outcomes https://t.co/RfrFpcxeWI #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @ASP_PharmD Wow that is amazing! #FTW #ASPchat |
| Brad Crane @ASP_PharmD Currently available products? MALDI, maybe @AXDXNews and a respiratory panel for LRTI that includes bacteria/viruses. Future/ultimate goal? Rapid ID with Rapid AST for all specimens... on one platform... that is inexpensive. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_PharmD: A4. We did pilot study - used it and compared outcomes (antibiotic utilization but especially ICU & hospital LOS & costs) - when I showed NET savings of $600k/year (incorporating cost of RDT), much easier to keep it going. #ASPchat |
| Monica Mahoney @mmPharmD @ASP_Chat A6. Small footprint. Affordable cost. Customizability (mimic formulary, add/subtract meds quickly). Incorporate new abx easily. Renally dose meds 😇 #ASPchat |
| Brad Langford @BRxAD @ASP_Chat Would be awesome to have a test to differentiate ASB from UTI in patients with dementia/mental status changes. Could have broad applicability beyond the acute care setting. #ASPchat |
| #ASPchat @ASP_Chat Q7 [for fun]. If antimicrobial stewardship had a 🎵 “theme song” what would it be? #ASPchat Let’s end on a lighter 🎶 note... |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @real_idpharmd: @KisgenUF agree with the MUE/resident research. Presented on Pharmacy Rules Everything Around MUEs #PREAM at @GSHPofficial meeting, one point made was when presenting data to C-suite, you should align your outcomes with senior leadership goal to better speak to admin #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @CDC_NCEZID: #BeAntibioticsAware materials for patients and healthcare providers are available in a variety of languages. #ASPChat https://t.co/sP1DnjF4dY |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_PharmD: I think lab appreciates it when pharmacy to the C-Suite asking for funds for the lab. #ASPchat |
| David Ha @DHpharmd Ridiculous request? Identifies true pathogen (organism + inflammatory markers), Antibiotic susceptibility, Any pathogen (bacteria, virus, fungus, etc), Any sample type, Point-of-care, Results in minutes, 100% sensitivity and specificity LOL #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @DHpharmd: Would say that 100% cost justification is often unrealistic, improvement in patient care (more optimal infxn treatment, maybe LOS) is the winner. Bring multiple disciplines &influential people (e.g. physician leaders) into the mix and you have a strong argument #ASPchat |
| Jordan Wong @real_idpharmd @ASP_Chat Something like this, portable. hand-held, point-of-care diagnostic tool. Maybe can rule out infection even before you can spell the word sepsis. #tricorder #icandream #ASPchat https://t.co/nB9TMUIK6Q |
| Monica Mahoney @mmPharmD #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @BnrdG @RodneyRohde @dest12 @romneyinla ooohhhh... we will be watching and waiting! #ASPchat https://t.co/47rnS3MLq5 |
| David Ha @DHpharmd @real_idpharmd @ASP_Chat .@real_idpharmd This is the winning tweet of this #ASPchat |
| Brad Crane @ASP_PharmD @IDstewardship Hospital & ICU LOS were primary causes of the significant savings. We even went to the CFO ahead of time so he could tell me how he wanted the numbers to be determined so he couldn't dispute them later. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @AXDXNews @DHpharmd @TheIDApprentice @ASP_Chat @TimbrookTT @real_idpharmd @manfordou @idpharmd Anyone know where can I get a good simple video explaining what morphokinetic cellular analysis is? #ASPchat |
| Jamie Kisgen @KisgenUF @AXDXNews PhenoSense and @BioFireDX LRTI panel probably have the most potential impactful for us. We got the Meningitis panel last year and it has been very helpful. #ASPChat #RDTWishList |
| #ASPchat @ASP_Chat 📢🙌🏼 Thank you to the wonderful people who came out tonight to talk about #rapiddiagnostics and #abxstewardship!! We hope u picked up a few pearls, we sure did!! #ASPchat Hope to see you next month! @KisgenUF @DHpharmd @TheIDApprentice @BRxAD @real_idpharmd @CDC_NCEZID et al! |
| David Ha @DHpharmd @IDstewardship @AXDXNews @TheIDApprentice @ASP_Chat @TimbrookTT @real_idpharmd @manfordou @idpharmd Will leave it to @AXDXNews, but I recall seeing a really cool video of time lapse microbial growth and MIC determination with FISH identification #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @DHpharmd: @SMcGrathICP @mmPharmD @ASP_Chat Check out https://t.co/rLOmQMAuNq for a nice review of literature on RDTs for BSI #ASPchat |
| David Ha @DHpharmd RT @real_idpharmd: @ASP_Chat Something like this, portable. hand-held, point-of-care diagnostic tool. Maybe can rule out infection even before you can spell the word sepsis. #tricorder #icandream #ASPchat https://t.co/nB9TMUIK6Q |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @ASP_PharmD If you are trending it, could be something to post on their local cork board, may help with CQI. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @real_idpharmd: @ASP_Chat When teaching the ID pharmacy residents I start with: @TheBack140 who started this game changing practice https://t.co/zSDm6zqEJS Another underrated article in my opinion as it has cost analysis https://t.co/nTKMf7TaLb And a general review https://t.co/0IgRwepCb0 #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_PharmD: @IDstewardship Initially, yes. But when micro realizes I/we speak their language and they won't have to answer a ton of questions back from nurses/physicians, they realize pharmacists are likely the most efficient people to call for this specific test. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @BRxAD: @ASP_Chat Would be awesome to have a test to differentiate ASB from UTI in patients with dementia/mental status changes. Could have broad applicability beyond the acute care setting. #ASPchat |
| David Ha @DHpharmd RT @ASP_PharmD: @KisgenUF Pharmacists can help with provider lack of knowledge. Lots easier to educate clinical pharmacy staff (or selected providers) vs all providers. In addition to interpreting results correctly, we incorporate stewardship principles at same time. #ASPchat |
| Monica Mahoney @mmPharmD @DHpharmd @ASP_Chat @PaulSaxMD Welcome to the jungle - any resistant GNRs (pun intended) Walk (pantera) - cellulitis/osteo/PJI Dirrty (christina aguilera) - gram stains #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @CDC_NCEZID: #BeAntibioticsAware static clings and stickers now available to order via CDC-INFO On Demand! Visit https://t.co/Q6HxPmDlm8 and select “antibiotic use” from the drop-down menu. #ASPChat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @real_idpharmd: @ASP_Chat @TheBack140 Other ones by @TheIDApprentice https://t.co/hNq02zC3Pp @TimbrookTT https://t.co/u4iwZfoDvY MALDI and outcomes https://t.co/RfrFpcxeWI #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @ASP_PharmD: @IDstewardship Hospital & ICU LOS were primary causes of the significant savings. We even went to the CFO ahead of time so he could tell me how he wanted the numbers to be determined so he couldn't dispute them later. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship RT @KisgenUF: @AXDXNews PhenoSense and @BioFireDX LRTI panel probably have the most potential impactful for us. We got the Meningitis panel last year and it has been very helpful. #ASPChat #RDTWishList |
| Monica Mahoney @mmPharmD @DHpharmd @ASP_Chat @PaulSaxMD Call me maybe - AST approval/pager #ASPchat |
| Accelerate @AXDXNews @IDstewardship @DHpharmd @TheIDApprentice @ASP_Chat @TimbrookTT @real_idpharmd @manfordou @idpharmd Think traditional culture + AI. Not unlike the tech used in automated driving to make decisions. We correlate the change in time to broth microdillution. #ASPchat |
 | Brandon Dionne @BWDionne @mmPharmD @ASP_Chat I think you basically just described a pharmacist. #ASPchat |
| Bug Pharmacist 💊🧫 Tim Gauthier @IDstewardship @mmPharmD @DHpharmd @ASP_Chat @PaulSaxMD I knew people would not disappoint! :-) ...call me maybe 🤣 #ASPchat |
#ASPChat content from Twitter.